Clinical Trial Update: Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial assessing the efficacy and safety of exenatide in Japanese patients with type 2 diabetes who are treated with oral antidiabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2009-12-31